Literature DB >> 28057485

Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.

Sadafumi Suzuki1, Wado Akamatsu2, Fumihiko Kisa1, Takefumi Sone1, Kei-Ichi Ishikawa3, Naoko Kuzumaki4, Hiroyuki Katayama5, Atsushi Miyawaki5, Nobutaka Hattori6, Hideyuki Okano7.   

Abstract

Patient-specific induced pluripotent stem cells (iPSCs) show promise for use as tools for in vitro modeling of Parkinson's disease. We sought to improve the efficiency of dopaminergic (DA) neuron induction from iPSCs by the using surface markers expressed in DA progenitors to increase the significance of the phenotypic analysis. By sorting for a CD184high/CD44- fraction during neural differentiation, we obtained a population of cells that were enriched in DA neuron precursor cells and achieved higher differentiation efficiencies than those obtained through the same protocol without sorting. This high efficiency method of DA neuronal induction enabled reliable detection of reactive oxygen species (ROS) accumulation and vulnerable phenotypes in PARK2 iPSCs-derived DA neurons. We additionally established a quantitative system using the mt-mKeima reporter system to monitor mitophagy in which mitochondria fuse with lysosomes and, by combining this system with the method of DA neuronal induction described above, determined that mitophagy is impaired in PARK2 neurons. These findings suggest that the efficiency of DA neuron induction is important for the precise detection of cellular phenotypes in modeling Parkinson's disease.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Dopaminergic neurons; Flow cytometry; Induced pluripotent stem cells; Mitophagy; Parkinson's disease

Mesh:

Substances:

Year:  2017        PMID: 28057485     DOI: 10.1016/j.bbrc.2016.12.188

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

Review 2.  iPS cells in the study of PD molecular pathogenesis.

Authors:  Melanie M Cobb; Abinaya Ravisankar; Gaia Skibinski; Steven Finkbeiner
Journal:  Cell Tissue Res       Date:  2017-12-12       Impact factor: 5.249

Review 3.  The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.

Authors:  Elizabeth R Sharlow; Mehmet Murat Koseoglu; George S Bloom; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2019-05-16       Impact factor: 1.738

Review 4.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

5.  Differentiation of Midbrain Dopaminergic Neurons from Human iPS Cells.

Authors:  Kei-Ichi Ishikawa; Risa Nonaka; Wado Akamatsu
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

Review 7.  Induced pluripotent stem cells for neural drug discovery.

Authors:  Atena Farkhondeh; Rong Li; Kirill Gorshkov; Kevin G Chen; Matthew Might; Steven Rodems; Donald C Lo; Wei Zheng
Journal:  Drug Discov Today       Date:  2019-01-18       Impact factor: 7.851

8.  iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates.

Authors:  A H Laperle; S Sances; N Yucer; V J Dardov; V J Garcia; R Ho; A N Fulton; M R Jones; K M Roxas; P Avalos; D West; M G Banuelos; Z Shu; R Murali; N T Maidment; J E Van Eyk; M Tagliati; C N Svendsen
Journal:  Nat Med       Date:  2020-01-27       Impact factor: 53.440

9.  Pluripotent Stem Cell Derived Neurons as In Vitro Models for Studying Autosomal Recessive Parkinson's Disease (ARPD): PLA2G6 and Other Gene Loci.

Authors:  Renjitha Gopurappilly
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Mechanism of Dopaminergic Nerve Transmission in Different Doses of Morphine Addiction and Stress-Induced Depression.

Authors:  Qing Ji; Xin Li
Journal:  J Healthc Eng       Date:  2021-05-11       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.